In:
Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 35, No. 15_suppl ( 2017-05-20), p. e18190-e18190
Abstract:
e18190 Background: When ASCO published Top Five List to improve cancer care in 2012, we applied the same principles to build local guidelines, resulting in first edition of our “Libro Blu” (Blue Book), named after a similar tool previously adopted by the Swiss institution IOSI. In 2015 a reform of Lombardy public health, with the establishment of ASST-VAL, covering a huge area with 5 hospitals, brought a further need for harmonization of our work; moreover, the increasing appearance of high cost drugs and the simultaneous restrictions in public health budget required a more rational expense. Methods: After first edition in 2012, Libro Blu underwent periodic updates. In 2015 a major revision took place; besides up-to-date guidelines in the management of specific cancers, edited by Oncology, Hematology and Radiation Therapy specialists, attention was paid to supportive care, with consultants from many other fields. All recommendations in Libro Blu derive from Italian and international guidelines, adapted to our local reality after multidisciplinary discussion, and have been approved after a final joint review. Results: The implementation of Libro Blu resulted in a more consistent application of treatment protocols in ASST-VAL, ensuring all patients the same standard of care, and allowed to raise the level of both specific cancer treatment and supportive care. Furthermore, guidelines for a rational use of drugs allowed to reduce costs in our institution. After one year, 2015 edition of Libro Blu was submitted for review by a number of Italian oncologists from other institutions. Following this review, we used the updated version of Libro Blu to build, with unconditional support from Eli Lilly, a mobile app that will soon be available for download. Conclusions: Libro Blu established a common standard of care in a broad area and allowed a cost reduction that is particularly relevant at this moment, with cancer care facing the appearance of many high cost drugs along with a spending review that involves the Italian health system. The review from other Italian oncologists ensured the adherence of Libro Blu to national guidelines and to state-of-the-art clinical practice. Finally, the mobile app will make consultation easier and will allow to share this tool across all Italian institutions.
Type of Medium:
Online Resource
ISSN:
0732-183X
,
1527-7755
DOI:
10.1200/JCO.2017.35.15_suppl.e18190
Language:
English
Publisher:
American Society of Clinical Oncology (ASCO)
Publication Date:
2017
detail.hit.zdb_id:
2005181-5
